Comparable stake leader
Michael J. Roberts
SEC ownership of ADAPTIN BIO, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001938571.
Disclosed value leader
Michael J. Roberts
Comparable rows
2/8
Latest evidence
08 Sep 2025
- Public ticker
- APTN on OTC
- Parsed ownership sources
-
3/4/5 and 13D/G
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Michael J. Roberts
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
2 of 8
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Michael J. Roberts
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
08 Sep 2025
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001938571
- Issuer location
- Charlotte, NC
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of ADAPTIN BIO, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Michael J. Roberts
Disclosed value leader
Michael J. Roberts
Comparable rows
2/8
Latest evidence
08 Sep 2025
3/4/5
13D/G
Lead comparable stake: 27%
6 rows are not safely comparable across share classes.
13D/G row: Michael J. Roberts
Quick read
Michael J. Roberts leads the comparable SEC ownership view at 27%.
2 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Michael J. Roberts's linked filing trail.
Comparable ownership
Top 2
Michael J. Roberts
27%
Simon Pedder
12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Michael J. Roberts |
3/4/5
13D/G
President and CEO, Director, 10%+ Owner
|
27%
from 13D/G
|
$12,093,021
2,598,854 shares
mixed-class rows
|
— | 08 Sep 2025 |
| Simon Pedder |
3/4/5
13D/G
Executive Chairman, Director, 10%+ Owner
|
12%
from 13D/G
|
$5,199,998
1,120,802 shares
mixed-class rows
|
— | 08 Sep 2025 |
| Lucius Partners LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
3,250,000 shares
|
— | 11 Feb 2025 |
| Timothy Maness |
3/4/5
Chief Financial Officer
|
—
class O/S missing
|
—
192,231 shares
|
— | 08 Sep 2025 |
| Anthony P. Zook |
3/4/5
Director
|
—
class O/S missing
|
—
109,847 shares
|
— | 08 Sep 2025 |
| J. Nick Riehle |
3/4/5
Director
|
—
class O/S missing
|
—
109,847 shares
|
— | 08 Sep 2025 |
| L. Arthur Hewitt |
3/4/5
Chief Development Officer
|
—
class O/S missing
|
—
109,847 shares
|
— | 08 Sep 2025 |
| Patrick Joseph Gallagher |
3/4/5
Director
|
—
class O/S missing
|
—
109,847 shares
|
— | 08 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 08 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-9 of 9 reporting-owner rows connected to ADAPTIN BIO, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
9
Largest Forms 3/4/5 holder
Michael J. Roberts
Net 12M change
$0
Latest report
08 Sep 2025
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Michael J. Roberts | President and CEO, Director, 10%+ Owner | $12,093,021 | Mixed | 08 Sep 2025 | ||
| Simon Pedder | Executive Chairman, Director, 10%+ Owner | $5,199,998 | Mixed | 08 Sep 2025 | ||
| Patrick Joseph Gallagher | Director | Mixed | 08 Sep 2025 | |||
| Timothy Maness | Chief Financial Officer | Mixed | 08 Sep 2025 | |||
| Anthony P. Zook | Director | Mixed | 08 Sep 2025 | |||
| J. Nick Riehle | Director | Mixed | 08 Sep 2025 | |||
| L. Arthur Hewitt | Chief Development Officer | Mixed | 08 Sep 2025 | |||
| Nathan P. Pereira | President, CEO, CFO, Director | Mixed | 09 Oct 2023 | |||
| Lucius Partners LLC | 10%+ Owner | Mixed | 11 Feb 2025 |
Recent insider transactions for ADAPTIN BIO, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Anthony P. Zook | Stock Option (right to buy) | Award | 109,847 | 109,847 | 08 Sep 2025 | Direct | ||||
| J. Nick Riehle | Stock Option (right to buy) | Award | 109,847 | 109,847 | 08 Sep 2025 | Direct | ||||
| Patrick Joseph Gallagher | Stock Option (right to buy) | Award | 109,847 | 109,847 | 08 Sep 2025 | Direct | ||||
| Michael J. Roberts | Stock Option (right to buy) | Award | 439,386 | 439,386 | 08 Sep 2025 | Direct | ||||
| Simon Pedder | Stock Option (right to buy) | Award | 192,231 | 192,231 | 08 Sep 2025 | Direct | ||||
| Timothy Maness | Stock Option (right to buy) | Award | 192,231 | 192,231 | 08 Sep 2025 | Direct | ||||
| L. Arthur Hewitt | Stock Option (right to buy) | Award | 109,847 | 109,847 | 08 Sep 2025 | Direct |
* marks a reported price that did not pass the local price check.